Your browser doesn't support javascript.
loading
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Capsid Assembly Modulator GST-HG141 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial.
Li, Cuiyun; Wu, Min; Zhang, Hong; Mai, Jiajia; Yang, Lizhi; Ding, Yanhua; Niu, Junqi; Mao, John; Wu, Wenqiang; Zhang, Dong; Tang, Yanan; Yan, Wenhao.
Affiliation
  • Li C; Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China.
  • Wu M; Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China.
  • Zhang H; Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China.
  • Mai J; Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China.
  • Yang L; Maternal and Child Health and Family Planning Service Center of Changchun, Changchun, China.
  • Ding Y; Phase I Clinical Trial Unit, First Hospital, Jilin University, Changchun, China.
  • Niu J; Department of Hepatology, First Hospital, Jilin University, Changchun, China.
  • Mao J; Fujian Cosunter Pharmaceutical Co., Ltd., Fuzhou, China.
  • Wu W; Fujian Cosunter Pharmaceutical Co., Ltd., Fuzhou, China.
  • Zhang D; Fujian Cosunter Pharmaceutical Co., Ltd., Fuzhou, China.
  • Tang Y; Fujian Cosunter Pharmaceutical Co., Ltd., Fuzhou, China.
  • Yan W; Fujian Cosunter Pharmaceutical Co., Ltd., Fuzhou, China.
Antimicrob Agents Chemother ; 65(10): e0122021, 2021 09 17.
Article de En | MEDLINE | ID: mdl-34280012

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus de l'hépatite B / Hépatite B chronique Type d'étude: Clinical_trials / Prognostic_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Antimicrob Agents Chemother Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus de l'hépatite B / Hépatite B chronique Type d'étude: Clinical_trials / Prognostic_studies Limites: Humans Pays/Région comme sujet: Asia Langue: En Journal: Antimicrob Agents Chemother Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique